Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Open-market buy CEO bought 10,730 shares at $2.33 ($25,001)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award CFO acquired 3,931 shares (grant or award)
  6. 4 Grant or award Dir Govt Relations/Sectry acquired 6,879 shares (grant or award)
  7. 4 Grant or award Exec.Vice Chairman/CEO/Pres. acquired 14,741 shares (grant or award)
  8. 4 Other acquisition Director acquired 8,358 shares (other)
  9. 4 Other acquisition Director acquired 8,358 shares (other)
  10. 4 Grant or award CFO acquired 4,789 shares (grant or award)
  11. 4 Grant or award Dir Govt Relations/Sectry acquired 8,381 shares (grant or award)
  12. 4 Grant or award Exec.Vice Chairman/CEO/Pres. acquired 17,960 shares (grant or award)
  13. 4 Other acquisition Director acquired 9,503 shares (other)
  14. 4 Other acquisition Director acquired 9,503 shares (other)
  15. 4 Grant or award CFO acquired 5,208 shares (grant or award)
  16. 4 Grant or award Dir Govt Relations/Sectry acquired 9,115 shares (grant or award)
  17. 4 Grant or award Exec.Vice Chairman/CEO/Pres. acquired 19,531 shares (grant or award)
  18. 4 Other acquisition Director acquired 8,264 shares (other)
  19. 4 Other acquisition Director acquired 8,264 shares (other)
  20. 4 Grant or award CFO acquired 4,433 shares (grant or award)

Page 7 of 31 · 615 filings